During the past decade, Leber- and Studienzentrum am Checkpoint conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Leber- and Studienzentrum am Checkpoint" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Federal Ministry of Health, Germany" with 1 trials as a collaborator, "German Center for Diabetes Research" with 1 trials as a collaborator, "Ministry of Innovation, Science and Research in North Rhine-Westphalia" with 1 trials as a collaborator and "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Leber- and Studienzentrum am Checkpoint" are "Hepatitis C, Chronic" (3 trials), "Hepatitis C" (1 trials), "Hepatitis C Virus Infection" (1 trials), "Non-Alcoholic Fatty Liver Disease" (1 trials) and "Non-alcoholic Fatty Liver Disease (NAFLD)" (1 trials). Many other conditions were trialed in "Leber- and Studienzentrum am Checkpoint" in a lesser frequency.

Most popular intervention types in "Leber- and Studienzentrum am Checkpoint" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin 10mg oral tablet / Semaglutide 1mg pen injector" (1 trials), "Empagliflozin 10mg oral tablet and placebo pen injector matching semaglutide" (1 trials), "GS-5885" (1 trials), "GS-9451" (1 trials) and "Placebo matching empagliflozin and placebo pen injector matching semaglutide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Leber- and Studienzentrum am Checkpoint" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Leber- and Studienzentrum am Checkpoint". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Leber- and Studienzentrum am Checkpoint, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Leber- and Studienzentrum am Checkpoint, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".